Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux
HEPCSEX
1 other identifier
observational
29
1 country
1
Brief Summary
The main objective of this study is to analyse sexual behavior of HIV + MSM in Bordeaux, who have sexually contracted hepatitis C between January 1st 2013, to January 31, 2017. These data will bring some improvement about prevention and maybe reduced the hepatitis C incidence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2017
CompletedFirst Posted
Study publicly available on registry
September 25, 2017
CompletedStudy Start
First participant enrolled
November 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2018
CompletedNovember 14, 2018
November 1, 2018
4 months
September 19, 2017
November 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analyse sexual behaviours among HIV positive MSM in Bordeaux, through semi-directed interviews
At inclusion (day 0)
Secondary Outcomes (2)
Identifying socio-sexual networks through phylogenetic analysis
At inclusion (day 0)
Describing the natural history of sexual hepatitis C in HIV positive MSM
At inclusion (day 0)
Study Arms (1)
MSM co-infected HIV-HCV
Interventions
semi-directed interviews in order to collect socio-behavioral data
Eligibility Criteria
Men who have sex with Men co-infected HIV-HCV
You may qualify if:
- Patient older than 18 years
- HIV-1 and/or HIV-2 confirmed Infection
- Men who have sex with Men
- Patients included in the "ANRS CO3Aquitaine cohort".
- A person who has received information about the protocol and has given oral consent and that his / her non-opposition is documented in his / her medical file.
You may not qualify if:
- Transfusion contamination
- Substance abuse IV out of SLAM context
- Refusal to consent to research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service des Maladies Infectieuses et Tropicales, Hôpital Pellegrin
Bordeaux, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Linda WITTKOP, MD, PhD
Université de Bordeaux - ISPED - Inserm 2129 - CHU de Bordeaux
- PRINCIPAL INVESTIGATOR
Charles CAZANAVE, Prof
University Hospital Bordeaux, France
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2017
First Posted
September 25, 2017
Study Start
November 8, 2017
Primary Completion
March 13, 2018
Study Completion
March 13, 2018
Last Updated
November 14, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share